Cointime

Variant Bio

company

About

Variant Bio is leveraging the power of human genetic diversity to discover new therapeutics.

  • 11 - 50

Highlights

Total Funding Amount
$105M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series B
Last Funding Money Raised
$105M
Industries
Biotechnology,Genetics,Medical,Therapeutics
Founded date
Jan 1, 2018
Number Of Employee
11 - 50
Operating Status
Active

Variant Bio is leveraging the power of human genetic diversity to discover new therapeutics. The company's focus is to identify individuals and populations around the world who are extreme outliers for traits of medical relevance and to use innovative sequencing and analytic approaches to identify genes and pathways linked to these traits.

Variant Bio was founded in 2018 and headquartered in Seattle, Washington.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$105M
Variant Bio has raised a total of $105M in funding over 2 rounds. Their latest funding was raised on Nov 9, 2021 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 9, 2021 Series B $105M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Variant Bio is funded by 1 investors. General Catalyst are the most recent investors.
Investor Name Lead Investor Funding Round
General Catalyst — Series B
Cointime
เนื้อหา
บริษัท